Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
about
Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisPrognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studiesThe C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.Cervical cancer systemic inflammation score: a novel predictor of prognosisComparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.Resection or Transplant in Early Hepatocellular Carcinoma.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis
P2860
Q26776504-266B2717-0F6B-4014-8060-6E225826E325Q33618490-59AC84A4-1D72-4EAA-9617-77BDBBA8ECD6Q36052780-974D9207-309C-44A3-86AD-F8512A5BC9AFQ37366321-3D5C7D12-826E-4798-B4D2-B0DFB968D448Q37465628-5E05B040-3913-4042-B9BD-6CB607D9377EQ39991182-240881D8-C329-4E8A-976F-1605955B801AQ40006646-0B3231E3-8CDE-48CE-AE54-5B162732A287Q40061509-19B68DDE-D7A8-4B7C-9AE1-02E650E84322Q40919364-6FE111D9-B888-453C-B23D-A796CF3AD669Q41461941-C8CDAE53-A081-4017-996C-9AE662CCF4C1Q42287550-90B1798D-E011-4719-B8EF-0CA0AD25825EQ47338550-5A2B0CD7-B422-4AAC-8F88-74BB6BBD0669Q47868312-EF933F46-DEC9-447C-91E7-192E9C590F81Q49211015-FB4DC434-998C-4C88-A36A-1422AB7DE815Q58795219-D23E9575-1969-4A07-9E55-25E46D73E4BF
P2860
Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@ast
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@en
type
label
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@ast
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@en
prefLabel
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@ast
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@en
P2093
P2860
P1433
P1476
Prognostic Value of the Modifi ...... y for Hepatocellular Carcinoma
@en
P2093
Hong-Wei He
Jia-Xing Wang
Jian-Jun Jin
Shuang-Jian Qiu
Xiao-Chun Ni
Xiao-Yan Cai
Yi-Peng Fu
P2860
P356
10.1097/MD.0000000000001486
P407
P577
2015-09-01T00:00:00Z